Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1471 AL 1485

Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer's Disease

Cummings J, Osse AML, Cammann D, Powell J, Chen J.

BioDrugs. 2024 Jan;38(1):5-22. doi: 10.1007/s40259-023-00633-2. Epub 2023 Nov 13.

Targeting autophagy in Alzheimer's disease: Animal models and mechanisms

Zhang XW, Zhu XX, Tang DS, Lu JH.

Zool Res. 2023 Nov 18;44(6):1132-1145. doi: 10.24272/j.issn.2095-8137.2023.294.

What the Gantenerumab Trials Teach Us about Alzheimer's Treatment

Schneider LS.

N Engl J Med. 2023 Nov 16;389(20):1918-1920. doi: 10.1056/NEJMe2310903.

A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease

Faridar A, Eid AM, Thome AD, Zhao W, Beers DR, Pascual MB, Nakawah MO, Roman GC, Davis CS, Grundman M, Masdeu JC, Appel SH.

Transl Neurodegener. 2023 Nov 16;12(1):54. doi: 10.1186/s40035-023-00387-5.

[The role of antidiabetic drugs in the treatment of Alzheimer's disease: systematic review]

Ishmuratova AN, Abramov MA, Kuznetsov KO, Ivanyuta MV, Shakirova ZF, Kitapova AI, Usmonov MD, Chernousova LM, Valeeva LI, Kuznetsova AY, Baislamov AS, Shaihetdinova AR, Mirgaliev AA, Orozberdiev ST, Yakupova KI.

Probl Endokrinol (Mosk). 2023 Nov 11;69(5):73-83. doi: 10.14341/probl13183.

Advances in amyloid-targeting monoclonal antibodies for Alzheimer's disease: clinical and public health issues

Salemme S, Ancidoni A, Locuratolo N, Piscopo P, Lacorte E, Canevelli M, Vanacore N.

Expert Rev Neurother. 2023 Jul-Dec;23(12):1113-1129. doi: 10.1080/14737175.2023.2284305. Epub 2023 Dec 15.

Efficacy of anti-amyloid-ß monoclonal antibody therapy in early Alzheimer's disease: a systematic review and meta-analysis

Dantas JM, Mutarelli A, Navalha DDP, Dagostin CS, Romeiro PHCL, Felix N, Nogueira A, Batista S, Teixeira L, Caramelli P.

Neurol Sci. 2024 Jun;45(6):2461-2469. doi: 10.1007/s10072-023-07194-w. Epub 2023 Nov 17.

NLRP3 Inflammasome: An Emerging Therapeutic Target for Alzheimer's Disease

Tao S, Fan W, Liu J, Wang T, Zheng H, Qi G, Chen Y, Zhang H, Guo Z, Zhou F.

J Alzheimers Dis. 2023;96(4):1383-1398. doi: 10.3233/JAD-230567.

Effect of Virgin Coconut Oil Supplementation on Cognition of Individuals with Mild-to-Moderate Alzheimer's Disease in Sri Lanka (VCO-AD Study): A Randomized Placebo-Controlled Trial

Fernando MG, Silva R, Fernando WMADB, de Silva HA, Wickremasinghe AR, Dissanayake AS, Sohrabi HR, Martins RN, Williams SS.

J Alzheimers Dis. 2023;96(3):1195-1206. doi: 10.3233/JAD-230670.

UNVEILING THE COMPLEX ROLE OF NF-ΚB IN ALZHEIMER'S DISEASE: INSIGHTS INTO BRAIN INFLAMMATION AND POTENTIAL THERAPEUTIC TARGETS

Verma Y, Sachdeva H, Kalra S, Kumar P, Singh G.

Georgian Med News. 2023 Sep;(342):133-141.

Safety, tolerability, pharmacokinetics and effects of diet on AD16, a novel neuroinflammatory inhibitor for Alzheimer's disease: a randomized phase 1 study

Peng D, Xu S, Zou T, Wang Y, Ouyang W, Zhang Y, Dong C, Li D, Guo J, Shen Q, Hu X, Zhou W, Li X, Qin Q.

BMC Med. 2023 Nov 23;21(1):459. doi: 10.1186/s12916-023-03126-9.

Clarity on the blazing trail: clearing the way for amyloid-removing therapies for Alzheimer's disease

Lian Y, Jia YJ, Wong J, Zhou XF, Song W, Guo J, Masters CL, Wang YJ.

Mol Psychiatry. 2024 Feb;29(2):297-305. doi: 10.1038/s41380-023-02324-4. Epub 2023 Nov 24.

Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms

Vuic B, Milos T, Tudor L, Nikolac Perkovic M, Konjevod M, Nedic Erjavec G, Farkas V, Uzun S, Mimica N, Svob Strac D.

Genes (Basel). 2023 Nov 6;14(11):2048. doi: 10.3390/genes14112048.

Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies

Alkhalifa AE, Al-Ghraiybah NF, Odum J, Shunnarah JG, Austin N, Kaddoumi A.

Int J Mol Sci. 2023 Nov 14;24(22):16288. doi: 10.3390/ijms242216288.

Research Progress on Natural Plant Molecules in Regulating the Blood-Brain Barrier in Alzheimer's Disease

Wu W, Huang J, Han P, Zhang J, Wang Y, Jin F, Zhou Y.

Molecules. 2023 Nov 16;28(22):7631. doi: 10.3390/molecules28227631.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias